Relationship Between Modality-specific Dual-task Performance and Immersive Exergaming Outcomes in Healthy Athletes (DUTACO)

March 26, 2026 updated by: Michelle C. Haas, Zurich University of Applied Sciences

The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answer are:

  • Can performance in visual and auditory dual-task paradigms explain performance in an immersive exergaming task in healthy athletes?
  • How are exergaming scores associated with athletic performance tests?
  • What biomechanical movement patterns are shown during dual-tasks? Researchers will also compare performance of those experienced with jumping and those inexperienced with jumping.

Participants will:

  • Complete two sessions performing athletic performance tests, cognitive tasks, and different dual-tasks while their movement pattern is recorded
  • Complete questionnaires on load, stress, and sleep during the sessions

Study Overview

Status

Recruiting

Conditions

Detailed Description

The two sessions last each approximately 2 hours and take place within one to 12 weeks. Both sessions involve measurement of biomechanical movement patterns with motion capture.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Canton of Zurich
      • Winterthur, Canton of Zurich, Switzerland, 8400
        • Recruiting
        • ZHAW Zurich University of Applied Sciences
        • Contact:
        • Contact:
        • Principal Investigator:
          • Michelle C. Haas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age between 18 and 34 years
  • self-reported recreationally or competitively active (more than 2 hours per week)
  • self-reported ability to complete change of direction, balancing, and jumping tasks
  • capacity to sign informed consent
  • ability to understand German

Exclusion Criteria:

  • acute injury in the last 6 months resulting in missing more than 3 training sessions
  • severe comorbidity or condition which would prohibit performance of the lsted testing tasks
  • self-reported pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dual-Task paradigms
All participants are exposed to the same dual-task paradigms described in the intervention.
Participants will perform combined motor-cognitive tasks. During the first session balancing and bilateral jumping will be combined with an additional auditory or visual cognitive task. During the second session participants will do a combined motor-cognitive task in exergaming.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive dual-task cost
Time Frame: Measurement session 1 (day 0) and session 2 (days 6-90)
Dual-task cost with the different modalities are operationalized by reaction time.
Measurement session 1 (day 0) and session 2 (days 6-90)
Exergaming performance
Time Frame: Session 2 (days 6-90)
Operationalized as task success rate
Session 2 (days 6-90)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor dual-task cost
Time Frame: Session 1 (day 0)
The motor dual-task costs are operationalized by the peak knee abduction angle.
Session 1 (day 0)
Countermovement Jump
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Height of a countermovement jump
Session 1 (day 0) and session 2 (day 6-90)
ProAgility Test
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Measured using the total elapsed time in the ProAgility Test.
Session 1 (day 0) and session 2 (day 6-90)
Y-Balance Test
Time Frame: Session 1 (day 0) and session 2 (days 6-90)
Measured using the composite reach distance in all directions of the Y-Balance Test.
Session 1 (day 0) and session 2 (days 6-90)
Joint Angle
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Angles of ankle, knee, and hip during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Joint Moment
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Moments of ankle, knee, and hip during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Ground Reaction Force
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Ground reaction force during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)
Center of pressure
Time Frame: Session 1 (day 0) and session 2 (day 6-90)
Center of pressure during the dual-tasks.
Session 1 (day 0) and session 2 (day 6-90)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

March 4, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • DUTACO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Pooled data of participants will be shared on a repository if consent is given by the participants.

IPD Sharing Time Frame

Within one year after completion of the study.

IPD Sharing Access Criteria

The access conditions will be defined in the license statement adjacent to the dataset.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Athlete

Clinical Trials on different dual-task paradigms

Subscribe